APA

Mawatari H., Kirikoshi H., Yoneda M., Higurashi T., Fujita K., Saito S., Inamori M., Takahashi H., Abe Y., Kubota K. & Nakajima A. (20090127). Effective treatment for advanced hepatocellular carcinoma with portal venous invasion using a combination therapy of intra-arterial 5-fluorouracil and subcutaneous pegylated-interferon-alpha-2b. : Hepato-gastroenterology.

Chicago

Mawatari Hironori, Kirikoshi Hiroyuki, Yoneda Masato, Higurashi Takuma, Fujita Koji, Saito Satoru, Inamori Masahiko, Takahashi Hirokazu, Abe Yasunobu, Kubota Kensuke and Nakajima Atsushi. 20090127. Effective treatment for advanced hepatocellular carcinoma with portal venous invasion using a combination therapy of intra-arterial 5-fluorouracil and subcutaneous pegylated-interferon-alpha-2b. : Hepato-gastroenterology.

Harvard

Mawatari H., Kirikoshi H., Yoneda M., Higurashi T., Fujita K., Saito S., Inamori M., Takahashi H., Abe Y., Kubota K. and Nakajima A. (20090127). Effective treatment for advanced hepatocellular carcinoma with portal venous invasion using a combination therapy of intra-arterial 5-fluorouracil and subcutaneous pegylated-interferon-alpha-2b. : Hepato-gastroenterology.

MLA

Mawatari Hironori, Kirikoshi Hiroyuki, Yoneda Masato, Higurashi Takuma, Fujita Koji, Saito Satoru, Inamori Masahiko, Takahashi Hirokazu, Abe Yasunobu, Kubota Kensuke and Nakajima Atsushi. Effective treatment for advanced hepatocellular carcinoma with portal venous invasion using a combination therapy of intra-arterial 5-fluorouracil and subcutaneous pegylated-interferon-alpha-2b. : Hepato-gastroenterology. 20090127.